Cross-cultural adaptation and validation of the French version of the Spinal Cord Injury Pain Instrument (SCIPI).

Autor: Reynard F; Department of Physiotherapy, Clinique romande de réadaptation Suva, Sion, Switzerland. fabienne.reynard@crr-suva.ch.; Department of Medical Research, Clinique romande de réadaptation Suva, Sion, Switzerland. fabienne.reynard@crr-suva.ch., Léger B; Department of Medical Research, Clinique romande de réadaptation Suva, Sion, Switzerland., Jordan X; Department of Paraplegia, Clinique romande de réadaptation Suva, Sion, Switzerland., Duong HP; Department of Medical Research, Clinique romande de réadaptation Suva, Sion, Switzerland.
Jazyk: angličtina
Zdroj: Spinal cord [Spinal Cord] 2022 Nov; Vol. 60 (11), pp. 990-995. Date of Electronic Publication: 2022 May 24.
DOI: 10.1038/s41393-022-00815-9
Abstrakt: Study Design: Cross-sectional.
Objectives: To assess the reliability and validity of the French version of the Spinal Cord Injury Pain Instrument (SCIPI) and to determine its performance versus "Douleur Neuropathique 4 questions" (DN4) in diagnosing neuropathic pain (NeuP).
Setting: Clinique romande de réadaptation, spinal cord injury (SCI) center in the French-speaking part of Switzerland.
Methods: Backward and forward translation in French of the 4-item SCIPI were performed by native speakers in both languages. Thirty persons with SCI were included in the validation study. Internal consistency was measured with the Kuder-Richardson (KR-20) coefficient. Cohen's kappa coefficients were used to assess the test-retest reliability and the agreement between SCIPI and DN4. Clinical assessment was used as the reference standard to diagnose NeuP. The area under the receiver operator characteristics curve (AUROC) was used to assess the performance of diagnostic tests.
Results: KR-20 coefficient of internal consistency was 0.50 (95% CI 0.26, 0.74). Test-retest reliability coefficient was 0.86 (95% CI 0.76, 0.95). The best cutoff value was 2 points, resulting a sensitivity of 88% (95% CI 69%, 98%) and a specificity of 92% (95% CI 75%, 99%). SCIPI had an AUROC of 0.90 (95% CI 0.82, 0.98), which was not significantly lower than the AUROC for DN4, 0.92 (95% CI 0.85, 0.99, p = 0.56). Agreement between SCIPI and DN4 was of 0.88 (95% CI 0.77, 1.00).
Conclusion: The French version of the SCIPI is a reliable and valid tool that can identify the presence of NeuP in an individual with SCI.
(© 2022. The Author(s), under exclusive licence to International Spinal Cord Society.)
Databáze: MEDLINE
Externí odkaz: